Academic Journal
Q1Journal of Hypertension
About Journal of Hypertension
Journal of Hypertension is a scholarly journal published by Lippincott Williams and Wilkins. SCImago 2025 places it in Q1 with an SJR of 1.069 and an H-index of 201.
Its listed coverage is 1983-2026 and its research categories include Cardiology and Cardiovascular Medicine (Q1); Internal Medicine (Q2); Physiology (Q2). The 2025 dataset reports 320 documents and 2359 citations across the latest three-year reporting window.
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
The journal publishes research related to Blood Pressure and Hypertension Studies, Cardiovascular Health and Disease Prevention, Hormonal Regulation and Hypertension, Heart Rate Variability and Autonomic Control, Sodium Intake and Health, Renin-Angiotensin System Studies.
Recent Research Articles
Latest publications matched automatically by ISSN.
Prognostic significance of invasive central and peripheral blood pressures for cardiovascular events and mortality
Giacomo Pucci, James E. Sharman, Riccardo Alcidi, Emanuele M. Perotti et al.
2026-09-02 · DOI: 10.1097/hjh.0000000000004428Impact of the new 2024 ESC blood pressure classification in a low-risk cohort: the 70 mmhg diastolic threshold may reduce risk discrimination in primary prevention
Maryne Lepoittevin, Pierre Bauvin, Alaedine Benani, Philippe Attias et al.
2026-09-02 · DOI: 10.1097/hjh.0000000000004434Blood pressure monitoring via wearable devices and artificial intelligence in hypertension detection
Luca Neri, Alessandro Orro, Nazareno Paolocci, Claudio Borghi et al.
2026-08-31 · DOI: 10.1097/hjh.0000000000004419Predictors of long-term all-cause mortality and incident disability in older hypertensive outpatients
Giulia Rivasi, Chiara Salucci, Giuseppe D’Ambrosio, Virginia Gori et al.
2026-08-31 · DOI: 10.1097/hjh.0000000000004431Hypertensive disorders of pregnancy and the risk for hypertension and cardiovascular and kidney disease. International Society of Hypertension position paper, endorsed by the World Hypertension League and European Society of Hypertension
Erika S.W. Jones, Udaya Ralapanawa, Pensee Wu, Lizzy M. Brewster et al.
2026-08-31 · DOI: 10.1097/hjh.0000000000004389Diagnostic recognition of primary aldosteronism in clinical practice
Arindam Bagga, Ramzi Ibrahim, Rahmeh Alasmar, Hoang Nhat Pham et al.
2026-08-31 · DOI: 10.1097/hjh.0000000000004430Marinobufagenin and left ventricular mass and geometry in patients with essential hypertension
Cristina Politi, Marco Mobrici, Alessandra Testa, Patrizia Pizzini et al.
2026-08-31 · DOI: 10.1097/hjh.0000000000004437Adrenalectomy versus esaxerenone: comparison of vascular benefits in patients with aldosterone-producing adenoma
Shinji Kishimoto, Tatsuya Maruhashi, Masato Kajikawa, Aya Mizobuchi et al.
2026-08-31 · DOI: 10.1097/hjh.0000000000004425Skeletal muscle index modulates the reduction of aortic pressure augmentation after foam rolling
Kaname Tagawa, Hibiki Kawatani, Jun Sugawara, Youngju Choi et al.
2026-08-31 · DOI: 10.1097/hjh.0000000000004424Wearable wrist-watch type cuff oscillometric blood pressure monitors: consensus statement by the European Society of Hypertension Working Group on blood pressure monitoring
George S. Stergiou, Ariadni Menti, Kei Asayama, Anastasios Kollias et al.
2026-10 · DOI: 10.1097/hjh.0000000000004415Blood pressure phenotypes and hypertension-associated cardiac damage
Maria Randjelovic, Magnus Wijkman, Karin Festin, Lisa Kastbom et al.
2026-10 · DOI: 10.1097/hjh.0000000000004406Deciphering the ‘superiority’ of recovery-estimated pulse wave velocity
Qingquan Wu, Guoqiu Pang
2026-10 · DOI: 10.1097/hjh.0000000000004262Nighttime blood pressure versus non-dipping for predicting asymptomatic organ damage in young individuals
Aikaterini Theodosiadi, Anastasios Kollias, Emelina Stambolliu, Angeliki Ntineri et al.
2026-10 · DOI: 10.1097/hjh.0000000000004392Professor John Low Reid, OBE, DM, FRCP, FRSE, FMedSci
Anna F. Dominiczak, Matthew R. Walters, Anthony Michael Heagerty, George F. Stergiou et al.
2026-10 · DOI: 10.1097/hjh.0000000000004403Corrigendum to “Arterial hypertension-attributable mortality in Europe, 2012–2021”
Marco Zuin
2026-10 · DOI: 10.1097/hjh.0000000000004385Sex differences in associations of periodontitis with blood pressure and arterial stiffening: the Hordaland Health Study
Ester Kringeland, Ellen Berggreen, Dagmar F. Bunæs, Gerhard Sulo et al.
2026-08-13 · DOI: 10.1097/hjh.0000000000004418Association of visit-to-visit blood pressure variability with kidney disease progression and cardiovascular outcomes in the chronic renal insufficiency cohort (CRIC)
Rushelle L. Byfield, Rachel Zhang, Alavi Hossain, Debbie L. Cohen et al.
2026-08-13 · DOI: 10.1097/hjh.0000000000004410Elevated urinary angiotensinogen excretion links incidence of chronic kidney disease among community-dwelling population: The Aging Kidney Study
Shun Yoshikoshi, Keisei Kosaki, Shoya Mori, Seiji Maeda et al.
2026-08-13 · DOI: 10.1097/hjh.0000000000004421Prognostic significance of the magnitude of the white-coat effect in hypertension
Alejandro de la Sierra, Natalie Staplin, Luis M. Ruilope
2026-08-13 · DOI: 10.1097/hjh.0000000000004416Long-term treatment with soluble guanylyl cyclase stimulator BAY41–8543 abolishes malignant hypertension-related mortality and attenuates organ damage: studies in Ren-2 transgenic rats treated with L-NAME
Martina Hüttl, Matúš Miklovič, Petra Škaroupková, Zdenka Vaňourková et al.
2026-08-13 · DOI: 10.1097/hjh.0000000000004422Reviews
Community Reviews
Version History
September 8, 2026 at 12:02 am
September 8, 2026